NASDAQ:RARE | Profit Margins | Ultragenyx Pharmaceutical Inc.

Complete source-backed margin history.

Available history
2016-12-31 to 2026-06-30
Data captured

Historical Profit Margins

DateGross marginOperating marginNet margin
2026-06-30-35.05%-42.99%
2026-03-31-124.26%-136.03%
2025-12-31-54.65%-62.02%
2025-09-30-106.85%-112.81%
2025-06-30-64.67%-68.86%
2025-03-31-102.88%-108.63%
2024-12-31-74.28%-80.90%
2024-09-30-94.62%-95.71%
2024-06-30-79.14%-89.51%
2024-03-31-151.93%-156.83%
2023-12-31-95.83%-97.17%
2023-09-30-147.98%-162.82%
2023-06-30-136.61%-147.57%
2023-03-31-153.34%-163.16%
2022-12-31-140.91%-146.91%
2022-09-30-248.14%-270.23%
2022-06-30-158.48%-177.03%
2022-03-31-170.93%-190.55%
2021-12-31-122.99%-146.85%
2021-09-30-110.02%-89.41%
2021-06-30-95.17%-140.76%
2021-03-31-107.22%-136.97%
2020-12-31-104.96%-26.23%
2020-09-30-61.76%-84.50%
2020-06-30-102.18%41.02%
2020-03-31-332.33%-327.81%
2019-12-31-265.37%-263.55%
2019-09-30-457.49%-437.96%
2019-06-30-465.75%-410.67%
2019-03-31-545.97%-532.45%
2018-12-31-555.56%-540.10%
2018-09-30-762.10%-742.24%
2018-06-30-741.75%-412.13%
2018-03-31-903.69%283.35%
2017-12-31-4011.35%-3385.71%
2017-09-30-42279.29%-40013.64%

Annual Profit Margins

DateGross marginOperating marginNet margin
2025-12-31-79.49%-85.44%
2024-12-31-95.71%-101.61%
2023-12-31-131.11%-139.86%
2022-12-31-178.60%-194.71%
2021-12-31-108.63%-129.20%
2020-12-31-121.80%-68.84%
2019-12-31-408.98%-388.31%
2018-12-31-721.18%-383.75%
2017-12-31-12593.49%-11567.34%
2016-12-31-186471.43%-184867.67%